SP
AGN

Solel Partners’s Allergan plc AGN Stock Holding History

Solel Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-223,400
Closed -$39.6M – 19
2020
Q1 		$39.6M Buy
223,400
+63,400
+40% +$11.9M 19.36% 2
2019
Q4 		$30.6M Buy
+160,000
New +$28.9M 17.16% 4

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Solel Partners's AGN Position: Q2 2020 in Review

Solel Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 223,400 shares — an estimated $39.6M sold.

Solel Partners first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $39.6M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Solel Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Solel Partners sold 223,400 Allergan plc shares in Q2 2020, an estimated $39.6M.
  • Solel Partners first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Solel Partners's Allergan plc position peaked at $39.6M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Solel Partners's 13F filing for Q2 2020, filed 14 Aug 2020.